The Senate Finance Committee today held a hearing on “tackling opioid and substance use disorders in Medicare, Medicaid and human services programs.” Chairman Orrin Hatch (R-UT) said he has already identified several areas of potential bipartisan support, including “the need to evaluate access to and utilization of non-opioid treatment options for managing pain; enhancing data-sharing to promote appropriate health care interventions and strengthen program integrity; and ensuring evidence-based care is available for patients to identify and treat opioid use disorders.” Ranking Member Ron Wyden (D-OR) called Medicaid “a key part of any solution.” He also criticized opioid drug makers and distributors for contributing to the crisis, and said “they need to be brought before this committee and held accountable.” Testifying at the hearing were Assistant Secretary for Health Brett Giroir, M.D., senior advisor to the HHS secretary on mental health and opioid policy, and Kimberly Brandt, principal deputy administrator for operations at the Centers for Medicare & Medicaid Services.

Related News Articles

Headline
The Department of Health and Human Services this week awarded $487 million in fiscal year 2019 grants to help states and territories increase access to…
Headline
The three medications approved by the Food and Drug Administration to treat opioid use disorder — methadone, buprenorphine and extended-release naltrexone —…
Headline
In a study of Blue Cross and Blue Shield enrollees reported last week in the New England Journal of Medicine, initial opioid prescriptions declined 54 percent…
Headline
The House Energy and Commerce Health Subcommittee today held a hearing on the president’s fiscal year 2020 budget request for the Department of Health and…
Headline
Eligible organizations can apply through May 6 for up to $1 million each for a three-year period to expand opioid and other substance use disorder services in…
Insights and Analysis
Birmingham VA Medical Center’s weekly, 90-minute shared medical appointments help veterans address opioid reliance.